Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis

BACKGROUND: Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors is a rare, relatively new and potentially fatal clinical entity, characterized by metabolic acidosis with normal or only moderately elevated glycemia. The mechanisms are not fully understood but involve increased ketogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitina, Michal, Lukes, Marek, Sramek, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103020/
https://www.ncbi.nlm.nih.gov/pubmed/37060078
http://dx.doi.org/10.1186/s12902-023-01339-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103020/
https://www.ncbi.nlm.nih.gov/pubmed/37060078
http://dx.doi.org/10.1186/s12902-023-01339-w

Ejemplares similares